Outlook Therapeutics (OTLK) Institutional Ownership $5.96 -0.04 (-0.67%) (As of 01:17 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Outlook Therapeutics (NASDAQ:OTLK)CurrentInstitutional OwnershipPercentage11.20%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$8.94MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$79.00M Get OTLK Insider Trade Alerts Want to know when executives and insiders are buying or selling Outlook Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OTLK Institutional Buying and Selling by Quarter Ad Monetary GoldTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Outlook Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Susquehanna Fundamental Investments LLC41,020$303K0.0%N/A0.175% 8/15/2024 AQR Capital Management LLC10,164$75K0.0%N/A0.043% 8/14/2024 Squarepoint Ops LLC31,388$232K0.0%N/A0.134% 8/14/2024 Great Point Partners LLC1,701,510$12.56M2.4%+15.0%7.270% 7/16/2024 LVW Advisors LLC47,730$352K0.1%N/A0.204% 7/12/2024 Rosalind Advisors Inc.450,000$3.32M2.4%+44.3%1.922% Shocking prediction from firm that predicted President Kamala (Ad)Prepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull off a victory and become our next president. And it would be much worse than anything you might expect—especially when it comes to your money. Because likely WON'T get a second chance at recovering the money you stand to lose if she takes power.Find out how to prepare.5/20/2024 Virtu Financial LLC18,213$217K0.0%-73.3%0.140% 5/14/2024 American International Group Inc.3,873$46K0.0%-95.0%0.030% 5/10/2024 Vanguard Group Inc.341,300$4.08M0.0%-94.8%2.623% 5/1/2024 BNP Paribas Financial Markets4,505$54K0.0%-94.8%0.035% 4/25/2024 Rosalind Advisors Inc.311,775$3.72M3.5%N/A2.396% 2/12/2024 Scotia Capital Inc.284,080$112K0.0%-16.1%0.109% 11/15/2023 Scotia Capital Inc.338,439$75K0.0%+420.9%0.130% 11/3/2023 Gables Capital Management Inc.154,500$34K0.0%+132.3%0.059% 10/24/2023 Bank of New York Mellon Corp434,567$96K0.0%-8.3%0.167% 9/21/2023 Barclays PLC30,963$54K0.0%-60.9%0.012% 8/7/2023 Lincoln National Corp320,300$557K0.0%+64.8%0.125% 8/4/2023 Main Street Financial Solutions LLC25,000$44K0.0%N/A0.010% 8/3/2023 Scotia Capital Inc.64,976$113K0.0%N/A0.025% 7/18/2023 Stratos Wealth Advisors LLC17,000$30K0.0%N/A0.007% 4/28/2023 SG Americas Securities LLC61,941$68K0.0%N/A0.024% 2/13/2023 GSA Capital Partners LLP277,785$300K0.0%+65.5%0.108% 2/10/2023 Vista Finance LLC277,615$300K0.4%-30.2%0.108% 2/8/2023 Lincoln National Corp194,300$210K0.0%+26.7%0.076% 2/7/2023 Metis Global Partners LLC48,289$52K0.0%+174.3%0.019% 1/17/2023 PPS&V Asset Management Consultants Inc.50,153$54K0.1%N/A0.022% 11/14/2022 Vista Finance LLC397,555$485K0.6%-61.0%0.176% 8/5/2022 Vista Finance LLC1,020,370$1.04M1.4%+3.7%0.452% 8/2/2022 Lincoln National Corp153,300$156K0.0%+48.4%0.068% 8/1/2022 Graypoint LLC37,500$38K0.0%-25.0%0.017% 7/26/2022 First Merchants Corp149,170$151K0.0%+45.1%0.066% 7/22/2022 LVW Advisors LLC1,733,633$1.77M0.4%-0.6%0.767% 7/18/2022 Gables Capital Management Inc.61,500$63K0.0%+32.3%0.027% 7/12/2022 Flower City Capital51,778$53K0.1%+158.9%0.023% 5/11/2022 GSA Capital Partners LLP256,200$456K0.1%+22.0%0.114% 5/2/2022 Gables Capital Management Inc.46,500$83K0.1%+1,228.6%0.021% 4/26/2022 Vista Finance LLC983,645$1.75M2.6%N/A0.439% 4/26/2022 First Merchants Corp102,770$182K0.0%+201.9%0.046% 4/19/2022 Graypoint LLC50,000$89K0.0%N/A0.022% 4/14/2022 Flower City Capital20,000$36K0.0%N/A0.009% Must-Know for Trading Options (Ad)Options are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.So make sure you claim your free seat by clicking here now.2/14/2022 GSA Capital Partners LLP210,042$286K0.0%N/A0.094% 2/10/2022 Alamar Capital Management LLC20,000$27K0.0%N/A0.009% 2/9/2022 Principal Financial Group Inc.36,686$50K0.0%+92.8%0.016% 2/8/2022 ProShare Advisors LLC19,461$26K0.0%+70.5%0.009% 2/8/2022 Northern Trust Corp817,545$1.11M0.0%-2.1%0.365% 2/7/2022 SG Americas Securities LLC25,235$34K0.0%-43.7%0.011% 2/4/2022 Envestnet Asset Management Inc.36,461$50K0.0%N/A0.016% 2/4/2022IndexIQ Advisors LLC187,692$255K0.0%-6.1%0.084% 2/2/2022 KWB Wealth27,284$37K0.0%N/A0.012% 2/2/2022 Oppenheimer & Co. Inc.22,100$30K0.0%+71.3%0.010% 1/27/2022 First Merchants Corp34,044$46K0.0%N/A0.015% 1/26/2022 Lincoln National Corp103,300$140K0.0%-59.2%0.046% 11/16/2021 Stelac Advisory Services LLC390,000$846K0.2%+39.3%0.222% 11/16/2021 Two Sigma Advisers LP309,900$672K0.0%-55.5%0.177% 11/16/2021 Two Sigma Investments LP271,534$589K0.0%-69.5%0.155% 11/15/2021 AXA S.A.145,013$315K0.0%-53.6%0.083% 11/12/2021 Renaissance Technologies LLC254,781$553K0.0%N/A0.145% 11/12/2021 Geode Capital Management LLC1,552,438$3.37M0.0%+2.4%0.885% 11/10/2021 Goldman Sachs Group Inc.151,110$328K0.0%+1,327.6%0.086% 11/10/2021IndexIQ Advisors LLC199,822$434K0.0%+11.1%0.114% 11/10/2021 Citigroup Inc.11,445$25K0.0%+174.5%0.007% 11/9/2021 Barclays PLC36,396$79K0.0%+113.8%0.021% 11/9/2021 BlackRock Inc.5,838,612$12.67M0.0%+1.5%3.330% 11/9/2021 Principal Financial Group Inc.19,025$41K0.0%+35.9%0.011% 11/5/2021 Advisor Group Holdings Inc.30,246$66K0.0%-52.6%0.017% 11/2/2021 New York State Common Retirement Fund35,884$78K0.0%-52.2%0.020% 11/1/2021 SG Americas Securities LLC44,828$97K0.0%N/A0.026% 10/29/2021Commonwealth Equity Services LLC21,522$46K0.0%N/A0.012% 10/28/2021Endurance Wealth Management Inc.15,000$33K0.0%N/A0.009% 10/22/2021 Strs Ohio27,000$58K0.0%+33.0%0.015% 10/18/2021 Coastal Investment Advisors Inc.16,000$35K0.0%+45.5%0.009% 8/17/2021 Walleye Capital LLC29,000$72K0.0%N/A0.017% 8/16/2021 Squarepoint Ops LLC11,200$28K0.0%-37.4%0.006% 8/16/2021 AQR Capital Management LLC35,995$90K0.0%N/A0.021% 8/16/2021 Amalgamated Bank16,537$41K0.0%N/A0.010% 8/16/2021 California State Teachers Retirement System121,237$302K0.0%N/A0.070% 8/16/2021 Charles Schwab Investment Management Inc.220,066$548K0.0%+539.1%0.127% 8/16/2021 State Street Corp1,342,514$3.34M0.0%N/A0.773% 8/16/2021 Nuveen Asset Management LLC187,652$468K0.0%N/A0.108% 8/13/2021 Northern Trust Corp880,428$2.19M0.0%+407.5%0.507% 8/13/2021 TrinityPoint Wealth LLC10,000$25K0.0%N/A0.006% 8/13/2021 Lincoln National Corp253,300$631K0.0%N/A0.146% 8/13/2021 AXA S.A.312,303$778K0.0%-24.6%0.180% 8/13/2021 Geode Capital Management LLC1,516,087$3.78M0.0%+104.4%0.873% 8/13/2021 Vanguard Group Inc.4,634,410$11.54M0.0%+11.3%2.669% 8/13/2021 ProShare Advisors LLC22,719$57K0.0%N/A0.013% 8/12/2021 XTX Topco Ltd10,871$27K0.0%N/A0.006% 8/12/2021 JPMorgan Chase & Co.33,623$84K0.0%N/A0.019% 8/11/2021 Bank of New York Mellon Corp232,474$578K0.0%+144.2%0.134% 8/11/2021 BlackRock Inc.5,753,938$14.33M0.0%+230.2%3.314% Shocking prediction from firm that predicted President Kamala (Ad)Prepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull off a victory and become our next president. And it would be much worse than anything you might expect—especially when it comes to your money. Because likely WON'T get a second chance at recovering the money you stand to lose if she takes power.Find out how to prepare.8/11/2021 Deutsche Bank AG51,992$129K0.0%N/A0.030% 8/10/2021 Principal Financial Group Inc.14,002$35K0.0%N/A0.008% 8/5/2021 Rhumbline Advisers45,986$115K0.0%N/A0.026% 8/2/2021 New York State Common Retirement Fund75,000$187K0.0%N/A0.043% 7/30/2021 Alliancebernstein L.P.17,000$42K0.0%N/A0.010% 5/19/2021 Virtu Financial LLC17,351$39K0.0%-84.4%0.010% 5/19/2021 Squarepoint Ops LLC17,886$40K0.0%N/A0.010% 5/18/2021 Millennium Management LLC200,013$450K0.0%+10.7%0.115% 5/18/2021 Citadel Advisors LLC176,362$397K0.0%+101.7%0.102% 5/17/2021 HRT Financial LP28,686$64K0.0%N/A0.017% (Data available from 1/1/2016 forward) OTLK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OTLK shares? During the previous two years, 22 institutional investors and hedge funds held shares of Outlook Therapeutics. The most heavily invested institutionals were Great Point Partners LLC ($12.56M), Vanguard Group Inc. ($4.08M), Rosalind Advisors Inc. ($3.32M), Lincoln National Corp ($557K), LVW Advisors LLC ($352K), Susquehanna Fundamental Investments LLC ($303K), and GSA Capital Partners LLP ($300K).Learn more on OTLK's institutional investors. What percentage of Outlook Therapeutics stock is owned by institutional investors? 11.20% of Outlook Therapeutics stock is owned by institutional investors. Learn more on OTLK's institutional investor holdings. Which institutional investors have been buying Outlook Therapeutics stock? Of the 15 institutional investors that purchased Outlook Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($450K), Scotia Capital Inc. ($338.44K), Great Point Partners LLC ($221.51K), Lincoln National Corp ($167K), GSA Capital Partners LLP ($109.96K), Gables Capital Management Inc. ($88K), and SG Americas Securities LLC ($61.94K). How much institutional buying is happening at Outlook Therapeutics? Institutional investors have bought a total of 1,689,990 shares in the last 24 months. This purchase volume represents approximately $23.40M in transactions. Which Outlook Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Outlook Therapeutics stock in the last 24 months: Vanguard Group Inc. ($6.22M), Vista Finance LLC ($742.76K), BNP Paribas Financial Markets ($81.88K), American International Group Inc. ($74.30K), Scotia Capital Inc. ($54.36K), Virtu Financial LLC ($49.93K), and Barclays PLC ($48.23K). How much institutional selling is happening at Outlook Therapeutics? Institutional investors have sold a total of 7,309,813 shares in the last 24 months. This volume of shares sold represents approximately $96.78M in transactions. Related Companies: Coherus BioSciences Institutional Ownership Champions Oncology Institutional Ownership Protara Therapeutics Institutional Ownership Brainstorm Cell Therapeutics Institutional Ownership Scholar Rock Institutional Ownership Replimune Group Institutional Ownership Rapport Therapeutics Institutional Ownership ProKidney Institutional Ownership Mesoblast Institutional Ownership Corbus Pharmaceuticals Institutional Ownership This page (NASDAQ:OTLK) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Outlook Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.